• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Modulating symptoms of early psychosis in Parkinson's disease using non-invasive brain stimulation

Research Project

Project/Area Number 21K15680
Research Category

Grant-in-Aid for Early-Career Scientists

Allocation TypeMulti-year Fund
Review Section Basic Section 52020:Neurology-related
Research InstitutionOsaka University

Principal Investigator

SUBHASH・REVANKAR Gajanan  大阪大学, 大学院医学系研究科, 特任助教(常勤) (70899773)

Project Period (FY) 2021-04-01 – 2025-03-31
Project Status Granted (Fiscal Year 2023)
Budget Amount *help
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2022: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2021: ¥2,600,000 (Direct Cost: ¥2,000,000、Indirect Cost: ¥600,000)
KeywordsCognitive neuroscience / Parkinson's disease / rTMS / EEG / Eye tracking / Illusions / Pareidolia / TMS / Psychosis / Neurostimulation
Outline of Research at the Start

Psychosis in Parkinson's disease adversely impairs patients' quality of life. In this proposal, we target a specific visual symptom of early psychosis called 'pareidolia' and utilize non-invasive brain stimulation in elucidating the role of frontal cortex in modulating symptoms of early psychosis.

Outline of Annual Research Achievements

We have created a database of potential patients for recruitment of patients with Parkinson's disease (PD) without dementia. The jRCT file have been revised considering the start of the new year (2024/4) although the project goals have remained unchanged.
We highlight the safety and efficacy data of cTBS stimulation in PD patients and contemplate its usage in the management of psychosis related symptoms such as hallucinations.
2 internal conference presentations have been done to disseminate information to the neurology residents. Site visit by Korean and international researchers was done in our department (Osaka University, Dept. of Neurology) to showcase our testing methodology. Some preliminary discussions with the Seoul National University Bundang hospital for a research collaboration were done.
A detailed methodological paper on the implementation of cTBS synchronized with Eye-tracking EEG paradigm is currenlty under submission. A case series report is being prepared. Some of the limitations with respect to the recruitment and the challenges invoved in patient testing have been highlighted.

Current Status of Research Progress
Current Status of Research Progress

1: Research has progressed more than it was originally planned.

Reason

Currently, some post hoc analysis and evaluation is being undertaken. Patient recruitment has been improvised and a well defined database is being accessed. Maintenance of the database is also performed. Since the initially planned number of patients was not feasible, a case series with similar level of diagnostic significance is achieved. While the methodology remains complex, a multidisciplinary nature of the project is highlighted in our work.
We recovered from some of the hardware challenges associated with cTBS positioning camera. Future challenges are expected in understanding the need and utilization of rTMS in clinical practice.

Strategy for Future Research Activity

The research will now proceed further in understanding how repeat stimulation of cTBS can achieve long term affects in visuoperceptual behavior. The primary use case for such a regimen is in the management of perceptual hallucinations phenomenon. However, more literature review will also be conducted in understanding the effects of repeated cTBS stimulation, efficacy and safety of such use. Although a single cTBS stim train has some stable after effects in visuoperception, long terms effects are unknown.

On a similar level, pareidolia perception is not restricted to PD alone. Other neurodegerative diseases are predisposed to such visuoperceptual deficits, for example, dementia with lewy body (DLB). PD and DLB share several pathological symptoms making rTMS useful for such patients.

Report

(3 results)
  • 2023 Research-status Report
  • 2022 Research-status Report
  • 2021 Research-status Report
  • Research Products

    (6 results)

All 2024 2023 2021

All Journal Article (2 results) (of which Peer Reviewed: 1 results,  Open Access: 1 results) Presentation (4 results) (of which Invited: 2 results)

  • [Journal Article] Perceptual constancy of pareidolias across paper and digital testing formats in neurodegenerative diseases2024

    • Author(s)
      Revankar Gajanan S.、Ozono Tatsuhiko、Suzuki Maki、et. al.
    • Journal Title

      medRxiv

      Volume: -

    • DOI

      10.1101/2024.02.08.24302504

    • Related Report
      2023 Research-status Report
  • [Journal Article] Prestimulus Low-Alpha Frontal Networks Are Associated with Pareidolias in Parkinson's Disease2021

    • Author(s)
      Revankar Gajanan S.、Kajiyama Yuta、Hattori Noriaki、Shimokawa Tetsuya、Nakano Tomohito、Mihara Masahito、Mori Etsuro、Mochizuki Hideki
    • Journal Title

      Brain Connectivity

      Volume: 11 Issue: 9 Pages: 772-782

    • DOI

      10.1089/brain.2020.0992

    • Related Report
      2021 Research-status Report
    • Peer Reviewed / Open Access
  • [Presentation] Patient-centric approach to utilizing visual misperception as a marker for neuropsychiatric disease2023

    • Author(s)
      Revankar, Gajanan
    • Organizer
      7th Joint Conference Rama- Hokkaido- Osaka University Joint symposium
    • Related Report
      2023 Research-status Report
    • Invited
  • [Presentation] Patient management tools for halluciantions in Parkinson's disease2023

    • Author(s)
      Revankar, Gajanan
    • Organizer
      ACCJ - HxD meeting Grand Front Umeda, Osaka
    • Related Report
      2023 Research-status Report
  • [Presentation] Why Japan Matters for the Global Startup Ecosystem2023

    • Author(s)
      Revankar, Gajanan
    • Organizer
      MEXT entrepreneuship program Kobe
    • Related Report
      2023 Research-status Report
    • Invited
  • [Presentation] Frontocortical deficits in Parkinson's disease patients susceptible to pareidolias2021

    • Author(s)
      Gajanan S. Revankar
    • Organizer
      62nd Annual Meeting of the Japanese Society of Neurology Inbox
    • Related Report
      2021 Research-status Report

URL: 

Published: 2021-04-28   Modified: 2024-12-25  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi